Article ID Journal Published Year Pages File Type
8541642 Journal of Pharmacy Research 2013 8 Pages PDF
Abstract
DSC and XRD study suggested loss of candesartan cilexetil crystallinity upon liquisolid formulation which was further confirmed by SEM, it indicates that drug is held within the powder substrate in a solubilized, almost molecularly dispersed state, which lead to the enhanced drug dissolution properties.
Keywords
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology, Toxicology and Pharmaceutics (General)
Preview
Design and development of liquisolid compact of candesartan cilexetil to enhance dissolution
Authors
, , ,